- Damon Runyon Fellowship Award
- Damon Runyon Clinical Investigator Award
- Damon Runyon-Rachleff Innovation Award
Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
Damon Runyon Fellowship Award
The Damon Runyon Fellowship Award supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be trained by established investigators in leading research laboratories across the country.
Starting with the Class of 2010, the Board of Directors has approved an increase in stipend for the Damon Runyon Postdoctoral Fellowship Award to $50,000 per year for three years for Level I funding and $60,000 per year for three years for Level II funding.
Dale F. Frey Award for Breakthrough Scientists **NEW**
At the end of the Fellowship, there are often a select few Damon Runyon Fellows
who have greatly exceeded the Foundation’s highest expectations. To catapult
their research careers—and their impact on cancer—the Foundation will make an
additional investment in these exceptional individuals by selecting them as
recipients of the Dale F. Frey Award for Breakthrough Scientists.
Damon Runyon Clinical Investigator Award
The Damon Runyon Clinical Investigator Award supports early career physician-scientists conducting patient-oriented research. The goal of this innovative program is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
Damon Runyon Clinical Investigators are eligible to apply for Continuation Grants in the final year of their award.
At the April 2010 meeting of the Clinical Investigator Award Committee, three Clinical Investigators were selected to receive Continuation Grants- Colleen Delaney, MD, MSc; Douglas K. Graham, MD, PhD; and Catherine J. Wu, MD.
Damon Runyon-Rachleff Innovation Award
The Damon Runyon-Rachleff Innovation Award supports the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer but lack sufficient preliminary data to obtain traditional funding.